Kayentis is a global leader in electronic Clinical Outcome Assessment (eCOA) and Decentralized Clinical Trial solutions. For over 20 years, it has partnered with pharma, biotechs and CROs in streamlining data collection and enhancing data quality across clinical trials worldwide. To date, Kayentis has supported more than 400 clinical trials across 30,000 sites in over 90 countries. Its expertise spans all clinical phases (I–IV) and more than 200 indications across 20+ therapeutic areas, delivering a comprehensive, science-driven and patient-centric suite of services. Operating across the US, Europe and Asia, Kayentis is recognized for its commitment to quality, innovation and operational excellence. With a 95.9% client recommendation rate in 2026, consistently rating above 90% over the past five years, Kayentis continuously adapts its solutions to meet the growing complexity of clinical trials and to improve outcomes for sponsors, sites and patients alike.
www.kayentis.com
